6Tausche AK, Richter K, Giassler A, et al. Severe gouty arthritirefractory to anti-inflammatory drugs: treatment with anti-tumouneerosis factor alpha as a new therapeutic option[J]. Ann RheumDis, 2004, 63 (10) : 1351.
7Beeher MA, Sehumacher HR, Wortamann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout[J].New Engl J Med . 2005. 353: 2450 - 2461.
8Mayer MD, Khosravan R, et al. Pharmacokinetics and pharmacodynamics of febuxoztat, a new non-purine selective inhibitor of xanthine oxidase, in subjects with renal impairment [J] . Am J Ther. 2005, 12: 22 - 34.
9Takano Y, Hase-Aoki K, et al. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase [J]. Life Sci, 2005, 76 : 1835 - 1847.
10Kong L D, Yang C, Ge F, et al. A Chinese herbalmedicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase inmice [J]. J E thnopharmacol, 2004, 93(2-3):325 -330.
